When Arena Pharmaceuticals (Nasdaq: ARNA) released positive Phase III data on its obesity drug, Lorcaserin, many people expected shares to take off. After all, the company’s press release on Monday confirmed that the drug had proven to be safe and effective.
Article
Investing in the Biotech Sector: 5 Elements To Consider
Posted, by MurrayRothbard on April 3rd, 2009
- Tickers:
- N/A
- Tags:
- Investment Ideas, backlinks, seo
Add new comment